Correlation Between Sunmax Biotechnology and Ruentex Development

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sunmax Biotechnology and Ruentex Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sunmax Biotechnology and Ruentex Development into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sunmax Biotechnology Co and Ruentex Development Co, you can compare the effects of market volatilities on Sunmax Biotechnology and Ruentex Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sunmax Biotechnology with a short position of Ruentex Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sunmax Biotechnology and Ruentex Development.

Diversification Opportunities for Sunmax Biotechnology and Ruentex Development

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Sunmax and Ruentex is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Sunmax Biotechnology Co and Ruentex Development Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ruentex Development and Sunmax Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sunmax Biotechnology Co are associated (or correlated) with Ruentex Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ruentex Development has no effect on the direction of Sunmax Biotechnology i.e., Sunmax Biotechnology and Ruentex Development go up and down completely randomly.

Pair Corralation between Sunmax Biotechnology and Ruentex Development

Assuming the 90 days trading horizon Sunmax Biotechnology Co is expected to generate 0.99 times more return on investment than Ruentex Development. However, Sunmax Biotechnology Co is 1.01 times less risky than Ruentex Development. It trades about 0.05 of its potential returns per unit of risk. Ruentex Development Co is currently generating about -0.06 per unit of risk. If you would invest  26,700  in Sunmax Biotechnology Co on September 17, 2024 and sell it today you would earn a total of  850.00  from holding Sunmax Biotechnology Co or generate 3.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.44%
ValuesDaily Returns

Sunmax Biotechnology Co  vs.  Ruentex Development Co

 Performance 
       Timeline  
Sunmax Biotechnology 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Sunmax Biotechnology Co are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Sunmax Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Ruentex Development 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ruentex Development Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Ruentex Development is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Sunmax Biotechnology and Ruentex Development Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sunmax Biotechnology and Ruentex Development

The main advantage of trading using opposite Sunmax Biotechnology and Ruentex Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sunmax Biotechnology position performs unexpectedly, Ruentex Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ruentex Development will offset losses from the drop in Ruentex Development's long position.
The idea behind Sunmax Biotechnology Co and Ruentex Development Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bonds Directory
Find actively traded corporate debentures issued by US companies
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance